Cargando…
A novel empeROR of pancreatic malignancy
How pancreatic cancer cells acquire tumor initiating capacities remains poorly understood. A recent study by Yamazaki et al (2023) uncovers a crucial, targetable role of tyrosine kinase‐like orphan receptor (ROR1) in PDAC tumor formation and progression.
Autores principales: | Peñuelas‐Haro, Irene, Espinet, Elisa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10350812/ https://www.ncbi.nlm.nih.gov/pubmed/37312634 http://dx.doi.org/10.15252/embj.2023114282 |
Ejemplares similares
-
TRPM4 and the Emperor
por: Simard, J. Marc, et al.
Publicado: (2017) -
Toward personalized TGFβ inhibition for pancreatic cancer
por: Carr, Ryan M, et al.
Publicado: (2019) -
A Ror recruit to mammary gland development
por: Short, Ben
Publicado: (2015) -
Patient‐derived organoids, creating a new window of opportunities for pancreatic cancer patients
por: Sandhya, Sandhya, et al.
Publicado: (2022) -
Malignant currents: sodium leak channel NALCN propels prostate cancer aggressiveness
por: Stejerean‐Todoran, Ioana, et al.
Publicado: (2023)